Modernization of laboratory oriented in diagnostic appropriateness and efficacy of treatments;La modernizzazione dei laboratori orientata all'appropriatezza diagnostica e all'efficacia dei trattamenti

Rivista di Medicina di Laboratorio

Volumn 5, Issue 2, 2004, Pages 147-163

  Cappelletti, Piro ^a,b  

^a Clinica Ostetrica e Ginecologica   (Italy)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSIS; EVIDENCE BASED MEDICINE; HEALTH MAINTENANCE ORGANIZATION; LABORATORY; LAW; MANAGED CARE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 4344667074     PISSN: 15923479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Pathology tests - Too much of a good thing. Lancet 1984; 1:1278-9.
2. Connelly D, Steele B. Laboratory utilization. Problems and solutions. Arch Pathol Lab Med 1980; 104:59-62.
3. McQueen MJ. Evidence-based Medicine: its application to Laboratory Medicine. Ther Drug Monit 2000; 22:1-9.
4. Denton TA, Diamond GA. For Goodness'Sake: expected therapeutic benefit as a basis for Healthcare delivery. Clin Chem 1995; 41:799-804.
5. Fraser CG, Woodford FP. Strategies to modify the test-requesting patterns of clinicians. Ann Clin Biochem 1987; 24:223-31.
6. Wong ET, Lincoln TL. Ready! Fire! Aim! An enquiry into laboratory test ordering. J Am Med Assoc 1983; 250:2510-3.
7. http://www.rand.org (data ultima consultazione 17.04.04).
8. Brook RH. Appropriateness: the next frontier. BMJ 1994; 308:218-9.
9. Phelps CE. The methodological foundations of studies of the appropriateness of medical care. N Engl J Med 1993; 329:1241-5.
10. Wong ET, Saxena S. Medical appropriateness of laboratory tests. Am J Clin Pathol 1992; 97:748-50.
11. Witte DL. Measuring outcomes: why now? Clin Chem 1995; 41:775-80.
12. College of American Pathologists. Standard for laboratory accreditation, 1996 edition. College of American Pathologists, Northfield (IL).
13. van Walraven C, Naylor CD. Do we know what inappropriate Laboratory utilization is? JAMA 1998; 280:550-8.
14. Hindmarsh JT, Lyon AW. Strategies to promote rational clinical chemistry test utilization. Clin Biochem 1996; 29:291-9.
15. Lundberg GD. The need for an outcome research agenda for clinical laboratory testing. JAMA 1998; 280:565-6.
16. The same as yesterday, laddie!: inappropriate laboratory tests. Bandolier 1998; 55:1-6.
17. Castellvì-Boada JM, Castells-Oliveres X. Appropriateness of physicians' requests of Laboratory examinations in Primary Health Care: an over- and under-utilization study. Clin Chem Lab Med 1999; 37:65-9.
18. Solomon DH, Hashimoto H, Daltroy L, Liang MH. Techniques to improve physicians' use of diagnostic tests. A new conceptual framework. JAMA 1998; 280:2020-7.
19. van Walraven C, Goel V, Chan B. Effect of population-based interventions on Laboratory utilization. A time-series analysis. JAMA 1998; 280:2028-33.
20. Winkelman JW. Less utilization of the clinical laboratory produces disproportionately small true cost reductions. Human Pathol 1984; 15:499-501.
21. Lundberg GD. Changing physician behavior in ordering diagnostic tests. JAMA 1998; 280:2036.
22. Winkelman JW, Hili RB. Clinical Laboratory responses to reduced funding. JAMA 1984; 252:2435-40.
23. Michel RL. Trends in clinical laboratory management. RCPath Bulletin 2003; 123:16-9.
24. Richardson H. Laboratory medicine in Ontario: its downsizing and the consequences on quality. Clin Chim Acta 1999; 290:57-72.
25. Mc Neil BJ. Shattuck Lecture - Hidden barriers to improvement in the quality of care. N Engl J Med 2001; 45:1612-29.
26. Burke MD. Clinical laboratory consultation: appropriateness to laboratory medicine. Clin Chim Acta 2003; 333:125-9.
27. st Century. In: Ward-Cook KM, Lehmann CA, Scoeff LE, Williams RH Eds. Clinical Diagnostic Technology. The total testing process. Volume 1: the preanalytical phase. Washington: AACCPress; 2003.
28. http://www.doh.gov.uk/pathologymodernisation/essentserv.htm (data ultima consultazione 17.04.04).
29. Genc M, Mardh P-A. A cost-effectiveness analysis of screening and treatment for Chlamidia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124:1-7.
30. Zarich S, Bradley K, Seymour J, Ghali W, Traboulsi A, Mayall ID, Bernstein L.Impact of troponin T determinations on hospital resources utilization and costs in the evaluation of patients with suspected myocardial ischemia. Am J Cardiol 2001; 88:732-6.
31. Morgan S, Hurley J, Miller F, Giacomini M. Predictive genetic tests and health system costs. CMAJ 2003; 168:989-91.
32. Winkens R, Dinant GJ. Rational, cost effective use of investigations in clinical practice. BMJ 2002; 324:783-5.
33. McAlister FA, Koon KT, Lewanczuk RZ, Wells G, Montagne TJ. Contemporary practice patterns in the management of newly diagnosed hypertension. Can Med Assoc J 1997; 157:23-30.
34. Light DW. The real ethics of rationing. BMJ 1997; 315:112-5.
35. Smellie WSA. Appropriateness of test use in pathology: a new era or reinventing the wheel? Ann Clin Biochem 2003; 40:585-92.
36. Smellie WSA, Galloway MJ, Chinn D, Gedling P. Is clinical practice variability the major reason for differences in pathology requesting patterns in general practice? J Clin Pathol 2002; 55:312-4.
37. Silverstein M. Clinical Chemistry Forum. Discussion. 1995; 41:813-6.
38. Plebani M. Appropriateness in programs for continuous quality improvement in clinical laboratories. Clin Chim Acta 2003 ;333:131-9.
39. Burke MD. Test selection strategies. Clin Lab Med 2002; 22:357.
40. Büttner J. Good Laboratory Practice: The Medical Aspects. Eur J Clin Chem Clin Biochem 1997; 35:251-6.
41. Shekelle PG, Kahan JP, Bernstein SJ, Leape LL, Kamberg CJ, Park RE. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 1998; 338:1888-95.
42. Marshall DA, O'Brien BJ. Economic evaluation of diagnostic tests. In: Price CP, Christenson RH Eds. Evidence-based Laboratory Medicine. From principles to outcomes. Washington: AACCPress; 2003.
43. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwing LM et al: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003; 49:7-18.
44. Price CP. Evidence-based Laboratory Medicine: supporting decision-making. Clin Chem 2000; 46:1041-50.
45. Bruns DE. Laboratory-related outcomes in Healthcare. Clin Chem 2001; 47:1547-52.
46. Smith BJ, McNeely MDD. The influence of an expert system for test ordering and interpretation on laboratory investigations. Clin Chem 1999; 45:1168-75.
47. van Wijk MA van der Lei J, Mosseveld M, Bohnen AM, van Bemmel JH. Assessment of decision support for blood test ordering in primary care. A randomized trial. Ann Int Med 2001;134: 274-81.
48. Sinclair D, Saas M, Stevens JM. The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice. J Clin Pathol 2004; 57:131-4.
49. Lock RJ. Rational requesting or rationing testing? J Clin Pathol 2004; 57:121-2.
50. Prinsloo PJJ, Gray TA. A survey of laboratory practice in the clinical authorization and reporting of results. Ann Clin Biochem 2003; 40:149-55.
51. LMPG Laboratory support for the diagnosis and monitoring of thyroid diseases. http://www.nacb.org/ lmpg/thyroid_lmpg_pub.stm (data ultima consultazione 17.4.2004)
52. Emerson JF, Emerson SS. The impact of requisition design on Laboratory utilization. Am J Clin Pathol 2001; 116:879-84.
53. Paterson JR, Paterson R. Reflective testing: how useful is the practice of adding on tests by laboratory clinicians? J Clin Pathol 1004; 57:273-5.
54. Smellie WSA, Lowrie R, Wilkinson E. A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary care. BMJ 2001; 323:1224-7.
55. Marshall WJ, Challand GS. Provision of interpretative comments on biochemical report forms. Ann Clin Biochem 2000; 37:758-63.
56. Vasikaran SD, Penberthy L, Gill J, Scott S, Sikaris KA. Review of a pilot quality-assessment program for interpretative comments. Ann Clin Biochem 2002; 39:250-60.
57. Prinsloo PJJ, Gray TA. A survey of laboratory practice in the clinical authorization and reporting of results. Ann Clin Biochem 2003; 40:149-55.
58. Lim EM, Sikaris KA, Gill J, Calleja J, Hickman PE, Beilby J, Vasikaran SD. Quality assessment of interpretative commenting in Clinical Chemistry. Clin Chem 2004; 50:632-7.
59. Kratz A, Soderberg BL, Szczepiorkowski KM, Dighe AS, Versalovic J, Laposata M. The generation of narrative interpretations in laboratory medicine. Am J Clin Pathol 2001; 116:S133-40.
60. Cunney RJ, Smyth EG. The impact of laboratory reporting practice on antibiotic utilization. Int J Antimicrobial Agents 2000; 14:13-9.
61. Kuo D, Gifford DR, Stein MD. Curbside consultation practices and attitudes among primary care physicians and medical subspecialists. JAMA 1998; 280:905-9.
62. Heard SR, Roberts C, Furrows SJ, Kelsey M, Southgate L. Corridor consultations and the medical microbiological record: is patient safety at risk? J Clin Pathol 2003; 56:43-7.
63. Morgan MS. Perceptions of a medical microbiology service: a survey of laboratory users. J Clin Pathol 1995; 48:915-8.
64. Laposata M. Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem 2004 ;50:471-2.
65. http://www.rcpath.org (data ultima consultazione 17.4.2004).
66. Rosenfeld L. Clinical Chemistry since 1800: growth and development. Clin Chem 2002; 48:186-97.
67. Cavicchi I. La privatizzazione silenziosa della sanità: cronaca sul razionamento del diritto alla salute. Roma: Datanews Editrice; 2004.
68. McQueen MJ. Overview of evidence-based medicine: challenger for evidence-based laboratori medicine. Clin Chem 2001; 47:1536-46